BlackThorn Therapeutics Garners $40,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cee3d7c-5f48-4100-bb21-1f7e9b01e8e2 - Date
10/21/2016 - Company Name
BlackThorn Therapeutics - Mailing Address
329 Oyster Point Blvd 3rd Floor South San Francisco, CA 94080 USA - Company Description
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments. - Website
http://www.blackthornrx.com - Transaction Type
Venture Equity - Transaction Amount
$40,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
Johnson & Johnson Development Corporation - Venture Investor
Altitude Life Science Ventures - Venture Investor
Mercury Fund - Venture Investor
Alexandria Venture Investments - Venture Investor
Undisclosed
